These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16886588)

  • 1. Bone mineral density and alterations of bone metabolism in children and adolescents with type 1 diabetes mellitus.
    Karagüzel G; Akçurin S; Ozdem S; Boz A; Bircan I
    J Pediatr Endocrinol Metab; 2006 Jun; 19(6):805-14. PubMed ID: 16886588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R; Gunczler P; Esaa S; Weisinger JR
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally.
    Gunczler P; Lanes R; Paz-Martinez V; Martins R; Esaa S; Colmenares V; Weisinger JR
    J Pediatr Endocrinol Metab; 1998; 11(3):413-9. PubMed ID: 11517957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
    Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
    Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type I collagen and bone mineral density in elderly men. Preliminary results.
    Lumachi F; Orlando R; Fallo F; Basso SM
    In Vivo; 2012; 26(6):1041-4. PubMed ID: 23160690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 1-year prospective study on the relationship between physical activity, markers of bone metabolism, and bone acquisition in peripubertal girls.
    Lehtonen-Veromaa M; Möttönen T; Irjala K; Nuotio I; Leino A; Viikari J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3726-32. PubMed ID: 11061531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus.
    Gunczler P; Lanes R; Paoli M; Martinis R; Villaroel O; Weisinger JR
    J Pediatr Endocrinol Metab; 2001 May; 14(5):525-8. PubMed ID: 11393573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
    Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lumbar spine bone mineral density in diabetic children with recent onset.
    De Schepper J; Smitz J; Rosseneu S; Bollen P; Louis O
    Horm Res; 1998; 50(4):193-6. PubMed ID: 9838239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1.
    Duman O; Ozdem S; Turkkahraman D; Olgac ND; Gungor F; Haspolat S
    Brain Dev; 2008 Oct; 30(9):584-8. PubMed ID: 18362054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
    Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y
    Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study.
    Duggan SN; Purcell C; Kilbane M; O'Keane M; McKenna M; Gaffney P; Ridgway PF; Boran G; Conlon KC
    Am J Gastroenterol; 2015 Feb; 110(2):336-45. PubMed ID: 25623657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
    Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
    Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
    Krupa B
    Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
    Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metabolism is linked to disease duration and metabolic control in type 1 diabetes mellitus.
    Brandao FR; Vicente EJ; Daltro CH; Sacramento M; Moreira A; Adan L
    Diabetes Res Clin Pract; 2007 Dec; 78(3):334-9. PubMed ID: 17582646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.